Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases.

Non-cancerous isolated colonocytes treated with butyrate showed a trend toward increasing SCAD levels, although this effect was not significant (Figure 3B ).

also in 53,322 other papers